vs
BRIGHT HORIZONS FAMILY SOLUTIONS INC.（BFAM）とPediatrix Medical Group, Inc.（MD）の財務データ比較。上の社名をクリックして会社を切り替えられます
BRIGHT HORIZONS FAMILY SOLUTIONS INC.の直近四半期売上が大きい（$733.7M vs $493.8M、Pediatrix Medical Group, Inc.の約1.5倍）。BRIGHT HORIZONS FAMILY SOLUTIONS INC.の前年同期比売上増加率が高い（8.8% vs -1.7%）。過去8四半期でBRIGHT HORIZONS FAMILY SOLUTIONS INC.の売上複合成長率が高い（8.5% vs -0.1%）
Bright Horizons Family Solutions Inc.は米国マサチューセッツ州ニュートンに本社を置く保育サービス事業者で、米国最大の企業主導型保育サービス提供会社です。予備保育・高齢者介護・授業料管理プログラム・教育アドバイス・学生ローン返済支援などのサービスも展開しています。
Pediatrix Medical Group, Inc.は米国を代表する専門医療サービスプロバイダーで、母胎医療、新生児科、小児心臓病学などの小児亜専門を中心に事業を展開し、米国全土の医療機関と提携して女性、新生児、子どもに根拠に基づく質の高い医療を提供しています。
BFAM vs MD — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $733.7M | $493.8M |
| 純利益 | — | $33.7M |
| 粗利率 | 19.3% | — |
| 営業利益率 | 6.2% | 9.9% |
| 純利益率 | — | 6.8% |
| 売上前年比 | 8.8% | -1.7% |
| 純利益前年比 | — | 10.5% |
| EPS（希薄化後） | $0.38 | $0.40 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $733.7M | $493.8M | ||
| Q3 25 | $802.8M | $492.9M | ||
| Q2 25 | $731.6M | $468.8M | ||
| Q1 25 | $665.5M | $458.4M | ||
| Q4 24 | $674.1M | $502.4M | ||
| Q3 24 | $719.1M | $511.2M | ||
| Q2 24 | $670.1M | $504.3M | ||
| Q1 24 | $622.7M | $495.1M |
| Q4 25 | — | $33.7M | ||
| Q3 25 | $78.6M | $71.7M | ||
| Q2 25 | $54.8M | $39.3M | ||
| Q1 25 | $38.0M | $20.7M | ||
| Q4 24 | — | $30.5M | ||
| Q3 24 | $54.9M | $19.4M | ||
| Q2 24 | $39.2M | $-153.0M | ||
| Q1 24 | $17.0M | $4.0M |
| Q4 25 | 19.3% | — | ||
| Q3 25 | 27.0% | — | ||
| Q2 25 | 25.0% | — | ||
| Q1 25 | 23.4% | — | ||
| Q4 24 | 20.8% | — | ||
| Q3 24 | 25.2% | — | ||
| Q2 24 | 24.2% | — | ||
| Q1 24 | 21.7% | — |
| Q4 25 | 6.2% | 9.9% | ||
| Q3 25 | 15.1% | 13.8% | ||
| Q2 25 | 11.8% | 12.8% | ||
| Q1 25 | 9.4% | 7.0% | ||
| Q4 24 | 7.2% | 7.8% | ||
| Q3 24 | 12.4% | 6.6% | ||
| Q2 24 | 10.3% | -31.3% | ||
| Q1 24 | 6.4% | 3.2% |
| Q4 25 | — | 6.8% | ||
| Q3 25 | 9.8% | 14.5% | ||
| Q2 25 | 7.5% | 8.4% | ||
| Q1 25 | 5.7% | 4.5% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | 7.6% | 3.8% | ||
| Q2 24 | 5.8% | -30.3% | ||
| Q1 24 | 2.7% | 0.8% |
| Q4 25 | $0.38 | $0.40 | ||
| Q3 25 | $1.37 | $0.84 | ||
| Q2 25 | $0.95 | $0.46 | ||
| Q1 25 | $0.66 | $0.24 | ||
| Q4 24 | $0.50 | $0.37 | ||
| Q3 24 | $0.94 | $0.23 | ||
| Q2 24 | $0.67 | $-1.84 | ||
| Q1 24 | $0.29 | $0.05 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $140.1M | $375.2M |
| 総負債低いほど良い | $747.6M | $570.5M |
| 株主資本純資産 | $1.3B | $865.9M |
| 総資産 | $3.9B | $2.2B |
| 負債/資本比率低いほどレバレッジが低い | 0.56× | 0.66× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $140.1M | $375.2M | ||
| Q3 25 | $116.6M | $340.1M | ||
| Q2 25 | $179.2M | $224.7M | ||
| Q1 25 | $112.0M | $99.0M | ||
| Q4 24 | $110.3M | $229.9M | ||
| Q3 24 | $109.9M | $103.8M | ||
| Q2 24 | $140.2M | $19.4M | ||
| Q1 24 | $63.7M | $8.0M |
| Q4 25 | $747.6M | $570.5M | ||
| Q3 25 | $747.5M | $577.2M | ||
| Q2 25 | $797.0M | $583.9M | ||
| Q1 25 | $872.7M | $590.5M | ||
| Q4 24 | $918.4M | $597.1M | ||
| Q3 24 | $925.7M | — | ||
| Q2 24 | $931.9M | — | ||
| Q1 24 | $938.1M | — |
| Q4 25 | $1.3B | $865.9M | ||
| Q3 25 | $1.4B | $890.7M | ||
| Q2 25 | $1.4B | $833.8M | ||
| Q1 25 | $1.3B | $789.2M | ||
| Q4 24 | $1.3B | $764.9M | ||
| Q3 24 | $1.4B | $732.5M | ||
| Q2 24 | $1.3B | $706.5M | ||
| Q1 24 | $1.2B | $856.2M |
| Q4 25 | $3.9B | $2.2B | ||
| Q3 25 | $3.9B | $2.2B | ||
| Q2 25 | $3.9B | $2.1B | ||
| Q1 25 | $3.8B | $2.0B | ||
| Q4 24 | $3.9B | $2.2B | ||
| Q3 24 | $3.9B | $2.1B | ||
| Q2 24 | $3.8B | $2.0B | ||
| Q1 24 | $3.8B | $2.2B |
| Q4 25 | 0.56× | 0.66× | ||
| Q3 25 | 0.52× | 0.65× | ||
| Q2 25 | 0.57× | 0.70× | ||
| Q1 25 | 0.66× | 0.75× | ||
| Q4 24 | 0.72× | 0.78× | ||
| Q3 24 | 0.66× | — | ||
| Q2 24 | 0.73× | — | ||
| Q1 24 | 0.76× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $350.7M | $114.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $258.5M | — |
| FCFマージンFCF / 売上 | 35.2% | — |
| 設備投資強度設備投資 / 売上 | 12.6% | — |
| キャッシュ転換率営業CF / 純利益 | — | 3.39× |
| 直近12ヶ月FCF直近4四半期 | $402.4M | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $350.7M | $114.1M | ||
| Q3 25 | $-17.6M | $137.3M | ||
| Q2 25 | $134.2M | $137.2M | ||
| Q1 25 | $86.2M | $-117.5M | ||
| Q4 24 | $337.5M | $133.0M | ||
| Q3 24 | $-8.9M | $91.8M | ||
| Q2 24 | $109.4M | $107.0M | ||
| Q1 24 | $116.3M | $-125.2M |
| Q4 25 | $258.5M | — | ||
| Q3 25 | $-42.4M | — | ||
| Q2 25 | $115.4M | — | ||
| Q1 25 | $70.9M | — | ||
| Q4 24 | $240.2M | — | ||
| Q3 24 | $-32.2M | — | ||
| Q2 24 | $86.8M | — | ||
| Q1 24 | $96.9M | — |
| Q4 25 | 35.2% | — | ||
| Q3 25 | -5.3% | — | ||
| Q2 25 | 15.8% | — | ||
| Q1 25 | 10.7% | — | ||
| Q4 24 | 35.6% | — | ||
| Q3 24 | -4.5% | — | ||
| Q2 24 | 13.0% | — | ||
| Q1 24 | 15.6% | — |
| Q4 25 | 12.6% | — | ||
| Q3 25 | 3.1% | — | ||
| Q2 25 | 2.6% | — | ||
| Q1 25 | 2.3% | — | ||
| Q4 24 | 14.4% | — | ||
| Q3 24 | 3.2% | — | ||
| Q2 24 | 3.4% | — | ||
| Q1 24 | 3.1% | — |
| Q4 25 | — | 3.39× | ||
| Q3 25 | -0.22× | 1.91× | ||
| Q2 25 | 2.45× | 3.49× | ||
| Q1 25 | 2.26× | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | -0.16× | 4.72× | ||
| Q2 24 | 2.79× | — | ||
| Q1 24 | 6.85× | -31.03× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
BFAM
セグメントデータなし
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
